Expanded Use Includes Adolescents (12+ Years)
Great news! The US FDA has reviewed and cleared the FAST1TM Intraosseous Infusion System for use in patients as young as 12 years of age.
Don’t Waste a Moment!
By the time a child reaches adolescence (12+ years of age) the sternum is large enough to accommodate the FAST1TM. That means emergency personnel now have the option to provide lifesaving fluids to younger patients more quickly than via alternative IO sites.
Safety First
The FAST1TM is designed to safely penetrate no more then 6 mm into the manubrium. Adult and adolescent patients have been proven to have a manubrium thickness large enough to make the procedure safe and highly effective.
Same FAST1TM - Greater Versatility
Expanded use of FAST1TM was granted by the FDA on the existing product design; no modifications to the device or its deployment were required.
Approved Worldwide
Pyng Medical has received approval for the expanded use from the US FDA, Health Canada and the European Union through its CE Mark.
